| 2430 |
1897: MyD88 activation |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 1584 |
1435: Increased NKA |
1223: Increased Airway Hyper-responsiveness,Cough, Dyspnea |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1585 |
1435: Increased NKA |
1225: Leukocyte infiltration |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1773 |
1435: Increased NKA |
1226: Respiratory irritability |
Sep 24, 2018 |
Sep 24, 2018 |
1 AOP
|
| 3535 |
2324: Dysregulation of Treg/Th17 cell ratio |
2325: Decreased number of LT CD8+ cells |
May 16, 2025 |
May 16, 2025 |
None
|
| 3538 |
2324: Dysregulation of Treg/Th17 cell ratio |
2326: CTL cytotoxicity |
May 22, 2025 |
May 22, 2025 |
1 AOP
|
| 1193 |
1147: increased or inappropriate, mantel display |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1219 |
1147: increased or inappropriate, mantel display |
1143: Depletion, energy reserves |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1220 |
1147: increased or inappropriate, mantel display |
1167: induced, parturition |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 3471 |
2303: Plasma estradiol/progesterone ratio, increase |
2251: Increased E2 availability |
Jan 10, 2025 |
Jan 14, 2025 |
1 AOP
|
| 3473 |
2303: Plasma estradiol/progesterone ratio, increase |
2306: Persistent vaginal cornification |
Jan 13, 2025 |
Jan 14, 2025 |
1 AOP
|
| 1954 |
1662: plasma homocysteine increases |
1663: brain Homocysteine level increases |
Jun 14, 2019 |
Jun 14, 2019 |
None
|
| 2902 |
2132: Increased cytokine expression |
1633: Increase in inflammation |
May 4, 2023 |
May 4, 2023 |
1 AOP
|
| 1719 |
1493: Increased pro-inflammatory mediators |
55: Cell injury/death |
Feb 1, 2018 |
Feb 12, 2018 |
1 AOP
|
| 1764 |
1493: Increased pro-inflammatory mediators |
265: Increase, HSC activation |
Aug 2, 2018 |
Aug 2, 2018 |
1 AOP
|
| 1777 |
1493: Increased pro-inflammatory mediators |
1494: Leukocyte recruitment/activation |
Nov 12, 2018 |
Nov 12, 2018 |
3 AOPs
|
| 1902 |
1493: Increased pro-inflammatory mediators |
1193: N/A, Breast Cancer |
May 7, 2019 |
May 10, 2019 |
2 AOPs
|
| 1903 |
1493: Increased pro-inflammatory mediators |
1632: Increase in RONS |
May 7, 2019 |
May 9, 2019 |
2 AOPs
|
| 1908 |
1493: Increased pro-inflammatory mediators |
1182: Increase, Cell Proliferation (Epithelial Cells) |
May 10, 2019 |
May 10, 2019 |
2 AOPs
|
| 2777 |
1493: Increased pro-inflammatory mediators |
2068: Increase, Endothelial Dysfunction |
Sep 28, 2022 |
Aug 26, 2024 |
1 AOP
|
| 1770 |
1226: Respiratory irritability |
1223: Increased Airway Hyper-responsiveness,Cough, Dyspnea |
Sep 24, 2018 |
Sep 24, 2018 |
1 AOP
|
| 2291 |
1847: SARS-CoV-2 production |
1392: Increase, Oxidative Stress |
Mar 25, 2021 |
Mar 25, 2021 |
None
|
| 2351 |
1847: SARS-CoV-2 production |
1848: TLR Activation/Dysregulation |
Apr 16, 2021 |
Apr 16, 2021 |
1 AOP
|
| 2358 |
1847: SARS-CoV-2 production |
1869: Diminished Protective Response to ROS |
Apr 20, 2021 |
Sep 26, 2023 |
2 AOPs
|
| 2488 |
1847: SARS-CoV-2 production |
1825: Increase, Cell death |
Oct 19, 2021 |
Oct 19, 2021 |
1 AOP
|